Efferon
Multimodal hemoadsorption therapy for sepsis, septic shock and cytokine storm
Community-submitted · content unverified. This organization has not verified ownership or the information in this profile.
About
Efferon develops single-use extracorporeal blood purification devices that remove bacterial endotoxin and excess cytokines from the bloodstream at the same time, targeting key molecular drivers of sepsis and acute inflammation. Its CE-marked devices include Efferon LPS for adults and Efferon NEO, which the company describes as the first multimodal device purpose-built for pediatric sepsis and septic shock. The company was selected for TechCrunch Disrupt 2026's Startup Battlefield 200 and says it is preparing to file for FDA approval.
- Website
- efferon.com
- Added via
- web
- Ownership
- unclaimed
Where to go
Products
- Efferon LPS — CE-marked adult blood purification device for sepsis and septic shock · Hardware
- Efferon NEO — Pediatric blood purification device built for sepsis in children · Hardware